New Delhi, Feb 6 (PTI) JB Chemicals & Pharmaceuticals on Tuesday said its net profit rose 26 per cent to Rs 134 crore for the third quarter ended December 2023.

The company reported a net profit of Rs 106 crore in the October-December period of the last fiscal.

Also Read | Union Bank of India Recruitment 2024: Applications Invited for 606 Specialist Officer Posts Till February 23, Apply Online at unionbankofindia.co.in.

Revenue increased to Rs 845 crore in the third quarter compared to Rs 793 crore in the year-ago period, JB Pharma said in a statement.

"Our focus on growing the domestic business ahead of the market continues, as reflected in the Q3 performance. The business once again stands out in this quarter," JB Pharma CEO and Wholetime Director Nikhil Chopra stated.

Also Read | Motilal Nehru Death Anniversary 2024 Date: Know All About the Day That Marks the Punyatithi of One of the Great Leaders of India.

In the international division, the formulations business is stable, he added.

"Our approach to develop progressive portfolios is on track, resulting in a positive impact for the exports branded generics business," Chopra said.

Shares of the company settled 1.18 per cent higher at Rs 1,724 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)